June 5th 2025
Valneva’s immunization, Ixchiq, was well tolerated in children ages 1 to 11 years regardless of the dose or previous chikungunya infection.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
Zika Linked with Cardiovascular Complications
March 14th 2017Researchers remind us that the Zika virus infection does not only cause complications in developing fetuses, after reports identified that nine patients from Venezuela presented with cardiovascular complications linked with the mosquito-borne infection.
Read More
No Correlation Found Between Asthma & the Development of Severe Dengue
March 10th 2017A group of researchers used data from St. Luke’s hospital network’s Sentinel Enhanced Dengue Surveillance Systems to investigate the association of asthma and the development of severe Dengue. Their findings were presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology.
Read More
Modifying Prenatal Care for Pregnant Women with Antenatal Microcephaly
March 3rd 2017Prenatal care for pregnant women with antenatal Zika-related microcephaly needs to be modified to include conversations that include pregnancy options as well as neonatal specialty consultations that will address infant special care needs, economic burden, and other factors.
Read More
Zika Infection Late in Pregnancy May Impact Fetal Neurologic Development
March 3rd 2017Carmen D. Zorrilla, MD, professor of obstetrics and gynecology, University of Puerto Rico, School of Medicine, shared her research which aimed to evaluate the growth patterns of fetuses whose mothers acquired Zika virus during pregnancy “and showed no prenatally detectable structural anomalies or maternal conditions that could affect fetal growth.”
Read More
Increase in Birth Defects Prompts CDC to Award Zika Surveillance Funding
March 2nd 2017The need for continued surveillance to provide estimates on the rate at which the virus has impacted the incidence of birth defects has prompted the Centers for Disease Control and Prevention (CDC) to award funding to five jurisdictions.
Read More
A Detailed Look at the Zika Virus Epidemic in Brazil
March 2nd 2017Pedro Fernando de Costa Vasconcelos, MD, PhD, director of the WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, took a closer look at the Zika virus in Brazil during his presentation at The First International Zika Conference.
Read More
Progressive & Delayed Hearing Loss Linked to Congenital Zika Infection
February 28th 2017At the First International Zika Conference, Viviane S. Boaventura, MD, PhD, researcher, Fiocruz-Bahia, Gonçalo Moniz Institute, Brazil, presented her research that depicting an association between Congenital Zika Syndrome and hearing loss.
Read More
Readiness is All: Replikins Give Advance Warning of Zika Outbreaks
February 28th 2017At the First International Zika Conference, Dr. Bogoch, professor of Emergency Medicine at Boston University School of Medicine, chairman at Replikins LLC, Foundation for Research on the Nervous System, explained how Replikins can give advanced warning of outbreaks and their cessation.
Read More
How Was Singapore's Zika Virus Outbreak Quickly Contained?
February 27th 2017Annelies Wilder-Smith, MD, PhD, professor at Lee Kong Chian School of Medicine in Singapore, discusses why the Zika virus outbreak in Singapore did not reach such large proportions as those that occurred in the Americas.
Watch
International Zika Registry to Estimate Magnitude of Risk of Congenital Zika Syndrome
February 25th 2017At the First International Conference on Zika Virus, Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, discussed how an international registry can help estimate the risk of Zika virus associated with birth defects and abnormal pregnancy outcomes.
Read More